Prof Magdalena Plebanski

Related Grants and Projects

• Principal investigator of A New Anti-Diabetes Drug as a Novel Therapy for Ovarian Cancer (funded by National Health and Medical Research Council)
• Participant in A randomised controlled trial of NMDA antagonist, memantine, for the treatment of borderline personality disorder (funded by National Health and Medical Research Council)
• Principal investigator of Innovative immune-based therapies and diagnostics: using nanotechnology for personalized medicine (funded by National Health and Medical Research Council)
• Participant in The effect of anti-fibrinolytic drugs on blood-brain barrier integrity and the immune response in traumatic brain injury (funded by National Health and Medical Research Council)
• Principal investigator of Use novel properties of nanoparticles to engineer and progress to the clinic 2nd generation therapeutics to tackle major human diseases including cancer, malaria and asthma (funded by National Health and Medical Research Council)
• View all 6 related grants and projects